Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings

Neurology

Volumn 83, Issue 11, 2014, Pages 1004-1011

  Berkowitz, Aaron L ^a   Westover, M Brandon ^b   Bianchi, Matt T ^b   Chou, Sherry H Y ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DECISION TREE; HUMAN; MORTALITY; NEUROIMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RECURRENCE RISK; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; STATISTICAL MODEL; ADULT; AGED; COST BENEFIT ANALYSIS; ECONOMICS; INTERNATIONAL COOPERATION; MIDDLE AGED; POVERTY; RECURRENT DISEASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TIME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; INTERNATIONALITY; MARKOV CHAINS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POVERTY AREAS; RECURRENCE; RISK FACTORS; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; STROKE; TIME FACTORS; YOUNG ADULT;

EID: 84908270353     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000779     Document Type: Article

References (33)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383:245-255.
2. Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Global Health 2013;1:e259-e281.
3. Brainin M, Teuschl T, Kalra L. Acute treatment and longterm management of stroke in developing countries. Lancet Neurol 2007;6:553-561.
4. Chen ZM, Sandercock P, Pan HC, Counell C, Collins R, Liu LS. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese acute stroke trial and the international stroke trial. Stroke 2000;31:1240-1249.
5. Johnson ES, Lanes S, Wentworth C, Satterfield M, Abebe BL, Dicker LW. A metaregression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med 1999;159:1248-1253.
6. He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 1998;280:1930-1935.
7. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378:1231-1243.
8. Runchey S, McGee S. Does this patient have a hemorrhagic stroke?: clinical findings distinguishing hemorrhagic stroke from ischemic stroke. JAMA 2010;303:2280-2286.
9. Berkowitz AL, Westover MB, BianchiMT, Chou SHY. Aspirin for acute stroke of unknown etiology in resource-limited settings: a decision analysis. Neurology 2014;83:787-793.
10. Pandian JD, Padma V, Vijaya P, Sylaja PN, Murthy JMK. Stroke and thrombolysis in developing countries. Int J Stroke 2007;2:17-26.
11. Berkowitz AL, Mittal M, Mclane HC, et al. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Int J Stroke 2014;9:349-355.
12. Feigin VL, Lawes CMM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review Lancet Neurol 2009;8:355-69.
13. Flynn R, MacDonald TM, Murray GD, MacWalter RS, Doney ASF. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke 2010; 41:2606-2611.
14. Huhtakangas J, Lopponen P, Tetri S, Juvela S, Saloheimo P, Bode MK. Predictors for recurrent primary intracerebral hemorrhage: a retrospective population-based study. Stroke 2013;44:585-590.
15. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-1860.
16. Wong KS; for the Asian Acute Stroke Advisory Panel. Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: A prospective hospital-based study in Asia. Stroke 1999;30:2326-2330.
17. Thompson BB, Béjot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 2010;75:1333-1342.
18. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-1703.
19. Anderson CS, Heeley R, Huang Y, et al. Rapid bloodpressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355-2365.
20. Eckman MH, Rosand J, Knudsen KA, Singer DE, Greenberg SM. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 2003;34: 1710-1716.
21. Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999; 159:677-685.
22. Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin and warfarin on quality of life. Arch Intern Med 1996;156:1829-1836.
23. National Center for Health Statistics. Vital Statistics in the United States, Volume II: Mortality. Washington, DC: Public Health Service, US Government Printing Office; 1988. Part A.
24. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123.
25. Zenebe G, Alemayehu M, Asmera J. Characteristics and outcomes of stroke at Tikur Anbessa Teaching Hospital, Ethiopia. Ethiop Med J 2005;43:251-259.
26. Matuja W, Janabi M, Kazema R, Mashuke D. Stroke subtypes in Black Tanzanians: a retrospective study of computerized tomography scan diagnoses at Muhimbili National Hospital, Dar es Salaam. Trop Doct 2004;34:144-146.
27. Nyame PK, Jumah KB, Adjei S. Computerised tomographic scan of the head in evaluation of stroke in Ghanians. East Afr Med J 1998;75:637-639.
28. Silberberg D, Katabira E. Neurological disorders. In: Jamison DT, Feachem RG, Makgoba MW, et al, editors. Disease and Mortality in Sub-Saharan Africa, 2nd ed. Washington, DC: World Bank; 2006. Chapter 23. Available at: http://www.ncbi.nlm.nih.gov/books/NBK2295/. Accessed February 17, 2014.
29. Ehrhardt S, Meyer CG. Transfer of evidence-based medical guidelines to low-and middle-income countries. Trop Med Int Health 2012;17:144-146.
30. Chinnock P, Siegfried N, ClarkeM. Is evidence-based medicine relevant to the developing world? PLoS Med 2005;2:e107.
31. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med 1987;316:250-258.
32. Monette J, Gurwitz JH, Rochon PA, Avorn J. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc 1997;45:1060-1065.
33. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010;9:167-76.